Abstract 64: Quality and feasibility of a protocol for simultaneous isolation of RNA, DNA and tissue for IHC from needle core lymph node biopsies in DLBCL adapted for multi-center trials.

Torsten H. Nielsen; Zuanel Diaz; Rosa Christodoulopoulos; Lu Yao; Samia Qureshi; Naciba Benlimame; Errol Camlioglu; Michael Crump; Ryan D. Morin; Nathalie Johnson; Tina P. Haliotis; Wilson H. Miller; Sarit Assouline; Koren K. Mann

doi:10.1158/1538-7445.AM2013-64

Abstract 64: Quality and feasibility of a protocol for simultaneous isolation of RNA, DNA and tissue for IHC from needle core lymph node biopsies in DLBCL adapted for multi-center trials.

Torsten H. Nielsen, Zuanel Diaz, Rosa Christodoulopoulos, Lu Yao, Samia Qureshi, Naciba Benlimame, Errol Camlioglu, Michael Crump, Ryan D. Morin, Nathalie Johnson, Tina P. Haliotis, Wilson H. Miller, Sarit Assouline, Koren K. Mann

Miami Cancer Institute

Research output: Contribution to journal › Article › peer-review

Original language	American English
Journal	Cancer research
Volume	73
DOIs	https://doi.org/10.1158/1538-7445.AM2013-64
State	Published - Apr 15 2013

Disciplines

Pathology
Internal Medicine
Medicine and Health Sciences
Immunology and Infectious Disease
Oncology

Access to Document

10.1158/1538-7445.AM2013-64License: Unspecified

Cite this

Nielsen, T. H., Diaz, Z., Christodoulopoulos, R., Yao, L., Qureshi, S., Benlimame, N., Camlioglu, E., Crump, M., Morin, R. D., Johnson, N., Haliotis, T. P., Miller, W. H., Assouline, S., & Mann, K. K. (2013). Abstract 64: Quality and feasibility of a protocol for simultaneous isolation of RNA, DNA and tissue for IHC from needle core lymph node biopsies in DLBCL adapted for multi-center trials. Cancer research, 73. https://doi.org/10.1158/1538-7445.AM2013-64

Nielsen, TH, Diaz, Z, Christodoulopoulos, R, Yao, L, Qureshi, S, Benlimame, N, Camlioglu, E, Crump, M, Morin, RD, Johnson, N, Haliotis, TP, Miller, WH, Assouline, S & Mann, KK 2013, 'Abstract 64: Quality and feasibility of a protocol for simultaneous isolation of RNA, DNA and tissue for IHC from needle core lymph node biopsies in DLBCL adapted for multi-center trials.', Cancer research, vol. 73. https://doi.org/10.1158/1538-7445.AM2013-64

@article{2215f5e201f646c3a0beb54800dee984,

title = "Abstract 64: Quality and feasibility of a protocol for simultaneous isolation of RNA, DNA and tissue for IHC from needle core lymph node biopsies in DLBCL adapted for multi-center trials.",

author = "Nielsen, {Torsten H.} and Zuanel Diaz and Rosa Christodoulopoulos and Lu Yao and Samia Qureshi and Naciba Benlimame and Errol Camlioglu and Michael Crump and Morin, {Ryan D.} and Nathalie Johnson and Haliotis, {Tina P.} and Miller, {Wilson H.} and Sarit Assouline and Mann, {Koren K.}",

note = "Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC Introduction: Personalized medicine strategies targeting specific aberrations unique to an individual tumor, are promising to become a new paradigm in the fight against cancer. Such tailored approaches rely on the thorough profiling of malignant tissues by high-throughput technologies followed by selection of appropriate treatment targeting tumor-specific aberrations.",

year = "2013",

month = apr,

day = "15",

doi = "10.1158/1538-7445.AM2013-64",

language = "American English",

volume = "73",

journal = "Cancer research",

}

TY - JOUR

T1 - Abstract 64: Quality and feasibility of a protocol for simultaneous isolation of RNA, DNA and tissue for IHC from needle core lymph node biopsies in DLBCL adapted for multi-center trials.

AU - Nielsen, Torsten H.

AU - Diaz, Zuanel

AU - Christodoulopoulos, Rosa

AU - Yao, Lu

AU - Qureshi, Samia

AU - Benlimame, Naciba

AU - Camlioglu, Errol

AU - Crump, Michael

AU - Morin, Ryan D.

AU - Johnson, Nathalie

AU - Haliotis, Tina P.

AU - Miller, Wilson H.

AU - Assouline, Sarit

AU - Mann, Koren K.

N1 - Proceedings: AACR 104th Annual Meeting 2013; Apr 6-10, 2013; Washington, DC Introduction: Personalized medicine strategies targeting specific aberrations unique to an individual tumor, are promising to become a new paradigm in the fight against cancer. Such tailored approaches rely on the thorough profiling of malignant tissues by high-throughput technologies followed by selection of appropriate treatment targeting tumor-specific aberrations.

PY - 2013/4/15

Y1 - 2013/4/15

UR - http://cancerres.aacrjournals.org/content/73/8_Supplement/64

U2 - 10.1158/1538-7445.AM2013-64

DO - 10.1158/1538-7445.AM2013-64

M3 - Article

VL - 73

JO - Cancer research

JF - Cancer research

ER -

Abstract 64: Quality and feasibility of a protocol for simultaneous isolation of RNA, DNA and tissue for IHC from needle core lymph node biopsies in DLBCL adapted for multi-center trials.

Disciplines

Access to Document

Other files and links

Cite this